Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Category 1: FDA-Approved Peptides These peptides have undergone rigorous clinical trials and received FDA approval for specific medical conditions
B12 + Methionine + Inositol + Choline Fat metabolism, liver function, weight management GLP-1 adjunct semaglutide, tirzepatide Weekly/bi-weekly for active programs Not sure which is right
If the peptides will be used immediately, or in the next several days, weeks or months, short-term refrigeration under 4C (39F) is generally acceptable
Week 3-4 (1 Month): With consistent weekly injections, improved diet, and regular exercise, some patients begin noticing changes in how their body processes fat
European Journal of Clinical Nutrition
AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
